Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.27B | 44.29B | 51.07B | 48.16B | 47.33B | 37.14B |
Gross Profit | 6.94B | 6.73B | 8.20B | 7.13B | 7.82B | 5.98B |
EBITDA | 3.83B | 184.00M | 4.93B | 4.23B | 4.80B | 3.51B |
Net Income | 592.00M | -2.25B | 1.19B | 700.00M | 1.01B | -654.00M |
Balance Sheet | ||||||
Total Assets | 38.38B | 36.67B | 39.90B | 39.40B | 38.34B | 35.23B |
Cash, Cash Equivalents and Short-Term Investments | 5.12B | 5.57B | 5.28B | 4.76B | 3.82B | 3.89B |
Total Debt | 6.91B | 7.47B | 6.61B | 8.22B | 9.47B | 11.02B |
Total Liabilities | 19.99B | 21.03B | 21.73B | 23.82B | 24.33B | 24.27B |
Stockholders Equity | 13.58B | 11.41B | 13.19B | 10.96B | 9.77B | 7.67B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 349.00M | 2.62B | 2.40B | 1.88B | 812.00M |
Operating Cash Flow | 0.00 | 2.21B | 4.32B | 4.68B | 4.61B | 2.60B |
Investing Cash Flow | 0.00 | -2.31B | -1.63B | -2.24B | -2.66B | -1.03B |
Financing Cash Flow | 0.00 | -212.00M | -2.37B | -1.65B | -2.32B | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥3.49B | 15.56 | 2.58% | 1.87% | -4.33% | ||
74 Outperform | ¥3.03B | 6.80 | 2.66% | 3.40% | 91.59% | ||
74 Outperform | ¥3.11B | 38.72 | 3.21% | -5.90% | -56.64% | ||
71 Outperform | ¥1.74B | 9.20 | 2.67% | 1.16% | 103.52% | ||
55 Neutral | ¥3.94B | ― | ― | -2.81% | 61.68% | ||
52 Neutral | ¥3.67B | 6.27 | 3.03% | -13.26% | -288.54% | ||
44 Neutral | C$972.16M | -6.67 | -13.73% | 2.49% | 17.55% | -32.57% |